WO2004101820A3 - Use of sah gene as a marker for psoriasis - Google Patents

Use of sah gene as a marker for psoriasis Download PDF

Info

Publication number
WO2004101820A3
WO2004101820A3 PCT/FR2004/001064 FR2004001064W WO2004101820A3 WO 2004101820 A3 WO2004101820 A3 WO 2004101820A3 FR 2004001064 W FR2004001064 W FR 2004001064W WO 2004101820 A3 WO2004101820 A3 WO 2004101820A3
Authority
WO
WIPO (PCT)
Prior art keywords
psoriasis
marker
sah gene
sah
gene
Prior art date
Application number
PCT/FR2004/001064
Other languages
French (fr)
Other versions
WO2004101820A2 (en
Inventor
Valerie Trinquet
Patricia Rossio
Michel Demarchez
Original Assignee
Galderma Res & Dev
Valerie Trinquet
Patricia Rossio
Michel Demarchez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Valerie Trinquet, Patricia Rossio, Michel Demarchez filed Critical Galderma Res & Dev
Publication of WO2004101820A2 publication Critical patent/WO2004101820A2/en
Publication of WO2004101820A3 publication Critical patent/WO2004101820A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a probe relating to the SAH gene for characterization of a biological sample. The invention also relates to the use of said probe in order to identify an compound for the treatment of psoriasis, an identification method and a novel search tool.
PCT/FR2004/001064 2003-05-07 2004-05-03 Use of sah gene as a marker for psoriasis WO2004101820A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0305571A FR2854639A1 (en) 2003-05-07 2003-05-07 Use of polynucleotide probe specific for the SAH gene in diagnosis of psoriasis and to screen for antipsoriatic agents, also therapeutic use by inhibiting SAH expression or activity
FR03/05571 2003-05-07

Publications (2)

Publication Number Publication Date
WO2004101820A2 WO2004101820A2 (en) 2004-11-25
WO2004101820A3 true WO2004101820A3 (en) 2005-01-20

Family

ID=33306221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/001064 WO2004101820A2 (en) 2003-05-07 2004-05-03 Use of sah gene as a marker for psoriasis

Country Status (2)

Country Link
FR (1) FR2854639A1 (en)
WO (1) WO2004101820A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955382A2 (en) * 1998-05-07 1999-11-10 Affymetrix, Inc. (a California Corporation) Polymorphisms associated with hypertension
WO2002044201A2 (en) * 2000-12-01 2002-06-06 Genaissance Pharmaceuticals, Inc. Haplotypes of the sah gene

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955382A2 (en) * 1998-05-07 1999-11-10 Affymetrix, Inc. (a California Corporation) Polymorphisms associated with hypertension
WO2002044201A2 (en) * 2000-12-01 2002-06-06 Genaissance Pharmaceuticals, Inc. Haplotypes of the sah gene

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BOWCOCK A M ET AL: "Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 10, no. 17, 15 August 2001 (2001-08-15), pages 1793 - 1805, XP002265788, ISSN: 0964-6906 *
DATABASE EMBL EBI; 28 October 2004 (2004-10-28), XP002304965, Database accession no. NM_005622 *
IWAI NAOHARU ET AL: "Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 105, no. 1, 1 January 2002 (2002-01-01), pages 41 - 47, XP001105333, ISSN: 0009-7322 *
NABIKA T ET AL: "Evaluation of the SA locus in human hypertension", HYPERTENSION, vol. 25, no. 1, 1995, pages 6 - 13, XP001104818, ISSN: 0194-911X *
OESTREICHER J L ET AL: "Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling", PHARMACOGENOMICS JOURNAL, NATURE PUBLISHING GROUP, GB, vol. 1, no. 4, 2001, pages 272 - 287, XP008036398, ISSN: 1470-269X *
PRADET-BALADE B ET AL: "Translation control: bridging the gap between genomics and proteomics?", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 26, no. 4, 1 April 2001 (2001-04-01), pages 225 - 229, XP004233580, ISSN: 0968-0004 *
ZHOU XIANGHONG ET AL: "Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.", PHYSIOLOGICAL GENOMICS. 18 MAR 2003, vol. 13, no. 1, 18 March 2003 (2003-03-18), pages 69 - 78, XP002304964, ISSN: 1531-2267 *

Also Published As

Publication number Publication date
FR2854639A1 (en) 2004-11-12
WO2004101820A2 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
WO2006137932A3 (en) Homogeneous analyte detection
WO2003008622A3 (en) Exponential nucleic acid amplification using nicking endonucleases
WO2003062462A3 (en) Method for isolating nucleic acids and protein from a single sample
WO2004052175A3 (en) Methods for rapid identification of pathogens in humans and animals
PL1871901T3 (en) Elite event a5547-127 and methods and kits for identifying such event in biological samples
WO2007019899A3 (en) Method for predicting the response to a treatment with a her dimerization inhibitor
WO2004055519A3 (en) Specific markers for pancreatic cancer
ATE522627T1 (en) METHOD FOR PRODUCING NUCLEIC ACID PROBE
WO2005118879A3 (en) Identification of tumors
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
EP2006393A4 (en) Method for analysing nucleic acids
WO2004044164A3 (en) Method for identifying risk of melanoma and treatments thereof
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
WO2003078603A3 (en) Strong gene sets for glioma classification
WO2005027710A3 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
AU2003211867A1 (en) Novel method of highly sensitive nucleic acid analysis
WO2007050735A3 (en) Markers for production traits
WO2004101820A3 (en) Use of sah gene as a marker for psoriasis
WO2006037102A3 (en) Methods for identifying polymerase inhibitors
AUPS064202A0 (en) Improved method for the analysis of nucleic acid samples
AU2003303869A1 (en) Methods for nucleic acid analysis
WO2004094661A3 (en) Fancc, dad1, grim19 and hadhii marker genes of psoriasis
WO2007066129A3 (en) A method of detecting skeletal muscle damage
WO2004094660A3 (en) Use of gene dpysl3 as a marker of psoriasis
EP1323835A3 (en) Method for determining biospecies contained in test specimen and kit used for the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase